Updates on Genetic Testing in Breast Cancer
In this video, Dr. Allison Kurian discusses polygenic risk scores, genetic testing in diverse populations, and more as they relate to breast cancer.
Can Circulating Tumor DNA Inform Breast Cancer Treatment?
In this video, Dr. Minetta Liu outlines current research into profiling breast cancer cell-free DNA in the blood, potentially to identify clinically aggressive breast cancer subtypes.
Exploring Current Tests, Treatments in Breast Cancer Management
In this video, Dr. Nancy Davidson highlights current and next-generation diagnostics and therapies in breast cancer, as well as the need for “team science” in clinical trials.
Bacterial Therapy May Be Promising in Cancer Patients
Dr. Filip Janku speaks with Cancer Network about a phase I clinical trial investigating the use of bacterial clostridium novyi-NT in solid tumors.
Why Haven’t Older Adults Been Included in More Oncology Clinical Trials?
In this video, Dr. Arti Hurria discusses resources addressing the disconnect between cancer as a growing problem in the elderly and the fact that clinical trials mostly enroll younger patients.
Tools and Tweaks to Improve Sleep Quality in Patients With Cancer
In this video, Dr. Jun Mao describes practical changes that have boosted sleep quality in cancer patients, and highlights results of a study showing sleep benefits from both CBT and acupuncture.
Men With Advanced Prostate Cancer, Be Informed About Your Genetics!
In this video, Dr. Heather Cheng briefly outlines the GENTleMEN study on the impact of genetic testing for men with advanced prostate cancer.
Strategies for Communicating Treatment Risks and Uncertainty of Outcomes
In this video, Professor Dame Lesley Fallowfield explains why oncologists need to be aware of their own tolerance of uncertainty before discussing possible treatment risks and outcomes with patients.
Liquid Biopsy to Inform Targeted Tx of Colorectal Cancer
In this video, Dr. Heinz-Josef Lenz outlines the many advantages that development of liquid biopsy is affording cancer patients.
AR-V7 Key in Tx of mCRPC
In this video, Dr. Andrew Armstrong explains why AR-V7–positive men rarely benefit from abiraterone or enzalutamide, and advises on AR-V7 testing as a clinical tool.
Can mRCC Patients Be Spared Debulking Nephrectomy?
In this video, Dr. Daniel George discusses CARMENA, which asked if cytoreductive surgery is necessary in the age of active systemic therapy for mRCC.
Impact and Implications of Lung Cancer Screening
In this video at ASCO 2018, James Mulshine, MD, discusses CMS coverage of low-dose CT lung cancer screening for selected Medicare beneficiaries, and clinical implications of early detection.
Evolving Use of ICIs and Targeted Tx in NSCLC and SCLC
In this video, Apar Ganti, MD, highlights recent advances and studies presented at ASCO 2018 on management of NSCLC and SCLC with ICIs and targeted agents.
Exploring the Changing Landscape of ICI Tx in NSCLC
In this video, Dr. Leena Gandhi discusses KEYNOTE-042, a study of pembrolizumab vs chemotherapy in NSCLC (abstract LBA4), and other key ICI trials reported at ASCO 2018.
Newer Targeted Approaches in Medullary Thyroid Cancer
In this video, Dr. Manisha Shah highlights new and emerging targeted therapies for medullary thyroid cancer, including research presented at ASCO 2018.
Breast Cancer and African Ancestry
In this video, Dr. Melissa Davis explains how African ancestry may play a role in breast cancer, and ways that genetics might be used to help guide treatment.
Small-Molecule TKIs: Potential Benefit in Multiple Malignancies
In this video, Dr. Brian Schwartz highlights several small-molecule TKIs in development with the potential to help patients with several malignancies.
ctDNA Increase May Predict Regorafenib Response in Advanced CRC
In this video, Pashalina Kehagias discusses how an early increase in ctDNA may predict a poor response to regorafenib in advanced CRC.
Xenograft Platform Could Lead to Mouse-Based Clinical Trials
In this video, Dr. Edison Liu describes a novel patient-derived xenograft platform that might enable development of a mouse-based clinical trials program.
Forecasting PARP Inhibitor Resistance in Breast Cancer Patients
In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in breast cancer, and the importance of understanding how resistance to these agents develops.
